The Impact of Anxiety and Depression Symptoms on Cardiovascular Risk Factor Control in Patients Without a History of Atherosclerotic Cardiovascular Disease

References

• Cohen BE, Edmondson D, Kronish IM. State of the art review: depression, stress, anxiety, and cardiovascular disease. AJHYPE. 2015;28(11):1295–1302. doi:10.1093/ajh/hpv047
   PubMed Web of Science ®Google Scholar
• Walli-Attaei M, Rosengren A, Rangarajan S, et al. Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study. Lancet. 2022;400(10355):811–821. doi:10.1016/S0140-6736(22)01441-6
   PubMed Web of Science ®Google Scholar
• Silverman AL, Herzog AA, Silverman DI. Hearts and minds: stress, anxiety, and depression: unsung risk factors for cardiovascular disease. Cardio Rev. 2019;27(4):202–207. doi:10.1097/CRD.0000000000000228
   PubMed Web of Science ®Google Scholar
• Javaid SF, Hashim IJ, Hashim MJ, Stip E, Samad MA, Ahbabi AA. Epidemiology of anxiety disorders: global burden and sociodemographic associations. Middle East Curr Psyc. 2023;30(1):44. doi:10.1186/s43045-023-00315-3
   Google Scholar
• Herrman H, Kieling C, McGorry P, Horton R, Sargent J, Patel V. Reducing the global burden of depression: a Lancet–World Psychiatric Association Commission. Lancet. 2019;393(10189):e42–e43. doi:10.1016/S0140-6736(18)32408-5
   PubMed Web of Science ®Google Scholar
• Lane D, Carroll D, Ring C, Beevers DG, Lip GYH. The prevalence and persistence of depression and anxiety following myocardial infarction. British J Health Psycho. 2002;7(1):11–21. doi:10.1348/135910702169321
   PubMedGoogle Scholar
• Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life: the heart and soul study. JAMA. 2003;290(2):215. doi:10.1001/jama.290.2.215
   PubMed Web of Science ®Google Scholar
• Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in Heart Failure. J American Coll Cardio. 2006;48(8):1527–1537. doi:10.1016/j.jacc.2006.06.055
   PubMed Web of Science ®Google Scholar
• Velten J, Lavallee KL, Scholten S, et al. Lifestyle choices and mental health: a representative population survey. BMC Psychol. 2014;2(1):58. doi:10.1186/s40359-014-0055-y
   PubMedGoogle Scholar
• Correll CU, Solmi M, Veronese N, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large scale meta analysis of 3211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163–180. doi:10.1002/wps.20420
   PubMed Web of Science ®Google Scholar
• Holvast F, Wouters H, Hek K, et al. Non-adherence to cardiovascular drugs in older patients with depression: a population-based cohort study. Int J Cardiol. 2019;274:366–371. doi:10.1016/j.ijcard.2018.08.100
   PubMed Web of Science ®Google Scholar
• Bremner J, Moazzami K, Wittbrodt M, et al. Diet, stress and mental health. Nutrients. 2020;12(8):2428. doi:10.3390/nu12082428
   PubMed Web of Science ®Google Scholar
• Ljungberg T, Bondza E, Lethin C. Evidence of the importance of dietary habits regarding depressive symptoms and depression. IJERPH. 2020;17(5):1616. doi:10.3390/ijerph17051616
   Web of Science ®Google Scholar
• Visseren FLJ, Mach F, Smulders YM, et al. ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–3337. doi:10.1093/eurheartj/ehab484
   PubMed Web of Science ®Google Scholar
• Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. Eur Heart J. 2014;35(21):1365–1372. doi:10.1093/eurheartj/eht462
   PubMed Web of Science ®Google Scholar
• Harshfield EL, Pennells L, Schwartz JE, et al. Association between depressive symptoms and incident cardiovascular diseases. JAMA. 2020;324(23):2396. doi:10.1001/jama.2020.23068
   PubMed Web of Science ®Google Scholar
• Balog P, Falger PRJ, Szabó G, Rafael B, Székely A, Konkolÿ Thege B. Are vital exhaustion and depression independent risk factors for cardiovascular disease morbidity? Health Psychol. 2017;36(8):740–748. doi:10.1037/hea0000495
   PubMed Web of Science ®Google Scholar
• Michas G, Karvelas G, Trikas A. Cardiovascular disease in Greece; the latest evidence on risk factors. Hellenic J Cardio. 2019;60(5):271–275. doi:10.1016/j.hjc.2018.09.006
   PubMed Web of Science ®Google Scholar
• Seldenrijk A, Vogelzangs N, Batelaan NM, Wieman I, van Schaik DJF, Penninx BJWH. Depression, anxiety and 6-year risk of cardiovascular disease. J Psychosom Res. 2015;78(2):123–129. doi:10.1016/j.jpsychores.2014.10.007
   PubMed Web of Science ®Google Scholar
• Kubica A, Michalski P, Kasprzak M, et al. Two different approaches to assess adherence to medication in Polish cohort of the EUROASPIRE V registry. Med Res J. 2022;7(2):108–113. doi:10.5603/MRJ.a2022.0015
   Google Scholar
• Ratajczak J, Kubica A, Michalski P, et al. Determinants of lipid parameters in patients without diagnosed cardiovascular disease—results of the polish arm of the EUROASPIRE V survey. JCM. 2023;12(7):2738. doi:10.3390/jcm12072738
   Google Scholar
• Kubica A, Pietrzykowski Ł, Michalski P, et al. The occurrence of cardiovascular risk factors and functioning in chronic illness in the Polish population of EUROASPIRE V. Cardiol J. 2022. doi:10.5603/CJ.a2022.0102
   Web of Science ®Google Scholar
• Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37(39):2999–3058. doi:10.1093/eurheartj/ehw272
   PubMed Web of Science ®Google Scholar
• Piepoli MF, Hoes AW, Agewall S, et al. European Guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts)developed with the special contribution of the European Association for cardiovascular prevention & rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381. doi:10.1093/eurheartj/ehw106
   PubMed Web of Science ®Google Scholar
• Perk J, De Backer G, Gohlke H, et al.; Authors/Task Force Members. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) *developed with the special contribution of the European Association for cardiovascular prevention & rehabilitation (EACPR). Eur Heart J. 2012;33(13):1635–1701. doi:10.1093/eurheartj/ehs092.
   PubMed Web of Science ®Google Scholar
• Pennells L, Kaptoge S, Østergaard HB, et al.; SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur Heart J. 2023;44(28):2544–2556. doi:10.1093/eurheartj/ehad260.
   PubMed Web of Science ®Google Scholar
• Sowada C, Sagan A, Kowalska-Bobko I Maresso, A. Poland: health system summary. Poland: Health System Summary (Copenhagen: WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies). 2022p. 3, 10.
   Google Scholar
• Lechowski Ł, Jasion A. Spatial Accessibility of Primary Health Care in Rural Areas in Poland. IJERPH. 2021;18(17):9282. doi:10.3390/ijerph18179282
   Web of Science ®Google Scholar
• Galiè N, Humbert M, Vachiery JL, et al. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (esc) and the European respiratory society (ers)endorsed by: Association for European paediatric and congenital cardiology (aepc), international society for heart and lung transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119. doi:10.1093/eurheartj/ehv317
   PubMed Web of Science ®Google Scholar
• Hageman S, Pennells L, Ojeda F, et al.; SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439–2454. doi:10.1093/eurheartj/ehab309.
   PubMed Web of Science ®Google Scholar
• De Vries TI, Cooney MT, Selmer RM, et al.; SCORE2-OP working group and ESC Cardiovascular risk collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021;42(25):2455–2467. doi:10.1093/eurheartj/ehab312.
   PubMed Web of Science ®Google Scholar
• Stern AF. The Hospital Anxiety and Depression Scale. Occup Med. 2014;64(5):393–394. doi:10.1093/occmed/kqu024
   Google Scholar
• De Smedt D, Clays E, Doyle F, et al. Validity and reliability of three commonly used quality of life measures in a large European population of coronary heart disease patients. Int J Cardiol. 2013;167(5):2294–2299. doi:10.1016/j.ijcard.2012.06.025
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
   PubMed Web of Science ®Google Scholar
• Kim JM, Stewart R, Lee YS, et al. Effect of escitalopram vs placebo treatment for depression on long-term cardiac outcomes in patients with acute coronary syndrome: a randomized clinical trial. JAMA. 2018;320(4):350–358. doi:10.1001/jama.2018.9422
   PubMed Web of Science ®Google Scholar
• Buszko K, Pietrzykowski Ł, Michalski P, et al. Validation of the Functioning in Chronic Illness Scale (FCIS). Med Res J. 2018;3(2):63–69. doi:10.5603/MRJ.2018.0011
   Google Scholar
• Chen ML, Chang HK, Yeh CH. Anxiety and depression in Taiwanese cancer patients with and without pain. J Adv Nurs. 2000;32(4):944–951. doi:10.1046/j.1365-2648.2000.t01-1-01560.x
   PubMed Web of Science ®Google Scholar
• Bunker SJ, Colquhoun DM, Esler MD, et al. “Stress” and coronary heart disease: psychosocial risk factors. Med J Aust. 2003;178(6):272–276. doi:10.5694/j.1326-5377.2003.tb05193.x
   PubMed Web of Science ®Google Scholar
• Jha MK, Qamar A, Vaduganathan M, Charney DS, Murrough JW. Screening and management of depression in patients with cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(14):1827–1845. doi:10.1016/j.jacc.2019.01.041
   PubMed Web of Science ®Google Scholar
• Vongmany J, Hickman LD, Lewis J, Newton PJ, Phillips JL. Anxiety in chronic heart failure and the risk of increased hospitalisations and mortality: a systematic review. Eur J Cardiovasc Nurs. 2016;15(7):478–485. doi:10.1177/1474515116635923
   PubMed Web of Science ®Google Scholar
• Levine GN, Cohen BE, Commodore-Mensah Y, et al. Psychological health, well-being, and the mind-heart-body connection: a scientific statement from the American heart Association. Circulation. 2021;143(10). doi:10.1161/CIR.0000000000000947
   Web of Science ®Google Scholar
• Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA. 1993;270(15):1819–1825. doi:10.1001/jama.1993.03510150053029
   PubMed Web of Science ®Google Scholar
• Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66(6):802–813. doi:10.1097/01.psy.0000146332.53619.b2
   PubMed Web of Science ®Google Scholar
• Novak Sarotar B, Lainscak M. Psychocardiology in the elderly. Wien Klin Wochenschr. 2016;128(Suppl 7):474–479. doi:10.1007/s00508-016-1139-x
   PubMedGoogle Scholar
• Eschweiler GW. Diagnostics and multimodal treatment of depression in old age: new developments. Z Gerontol Geriatr. 2017;50(2):99–105. doi:10.1007/s00391-016-1174-2
   PubMed Web of Science ®Google Scholar
• Palmiero P, Zito A, Maiello M, et al. Primary prevention of cardiovascular risk in octogenarians by risk factors control. CHYR. 2019;15(2):78–84. doi:10.2174/1573402115666190211160811
   Google Scholar
• Milaneschi Y, Simmons WK, van Rossum EFC, Penninx BW. Depression and obesity: evidence of shared biological mechanisms. Mol Psychiatry. 2019;24(1):18–33. doi:10.1038/s41380-018-0017-5
   PubMed Web of Science ®Google Scholar
• Kapfhammer HP. The relationship between depression, anxiety and heart disease - A psychosomatic challenge. Psychiatry Danub. 2011;23(4):412–424.
   PubMed Web of Science ®Google Scholar
• Kent LK, Shapiro PA. Depression and related psychological factors in heart disease. Harv Rev Psychiatry. 2009;17(6):377–388. doi:10.3109/10673220903463333
   PubMed Web of Science ®Google Scholar
• Marazziti D, Rutigliano G, Baroni S, Landi P, Dell’Osso L. Metabolic syndrome and major depression. CNS Spectr. 2014;19(4):293–304. doi:10.1017/S1092852913000667
   PubMed Web of Science ®Google Scholar
• Sin NL, Kumar AD, Gehi AK, Whooley MA. Direction of association between depressive symptoms and lifestyle behaviors in patients with coronary heart disease: the heart and soul study. Ann Behav Med. 2016;50(4):523–532. doi:10.1007/s12160-016-9777-9
   PubMed Web of Science ®Google Scholar
• Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002;288(22):2880–2883. doi:10.1001/jama.288.22.2880
   PubMed Web of Science ®Google Scholar
• Sabaté E. World Health Organization. editor. Adherence to Long-Term Therapies: evidence for Action. World Health Organization. 2003;1:1.
   Google Scholar
• Kubica A, Kasprzak M, Obońska K, et al. Discrepancies in assessment of adherence to antiplatelet treatment after myocardial infarction. Pharmacology. 2015;95(1–2):50–58. doi:10.1159/000371392
   PubMed Web of Science ®Google Scholar
• Teo KK, Rafiq T. Cardiovascular risk factors and prevention: a perspective from developing countries. Cana J Cardiol. 2021;37(5):733–743. doi:10.1016/j.cjca.2021.02.009
   PubMed Web of Science ®Google Scholar
• Martelli E, Enea I, Zamboni M, et al. Focus on the most common paucisymptomatic vasculopathic population, from diagnosis to secondary prevention of complications. Diagnostics. 2023;13(14):2356. doi:10.3390/diagnostics13142356
   Web of Science ®Google Scholar